Newborn Screening Cooperative Agreement Awarded to APHL for Implementation of SCID Testing
(firmenpresse) - SILVER SPRING, MD -- (Marketwired) -- 09/24/14 -- The has been awarded $4 million through a two-year cooperative agreement with the Genetic Services Branch of the U.S. Health and Human Services . In close partnership with the , APHL will provide technical assistance, education, and financial support to state newborn screening programs in order fully implement testing for .
Babies born with SCID (also known as "Bubble Boy Disease") lack a functioning immune system and often die within their first year of life. Early detection through allows for life-saving medical intervention. To date, less than half of US states . While many other states have approved the addition of SCID to their newborn screening panel, they have not yet been able to implement screening due to considerable challenges such as integration of new technology, the need for greater laboratory capacity and necessary training within the broader newborn screening system.
"Because SCID testing requires different technology and different clinical follow-up than the other conditions on HRSA''s , implementation has been out of reach for many states," said Dr. Marci Sontag, associate professor of epidemiology at the Colorado School of Public Health. "We aim to provide the support necessary to make SCID testing a reality around the country."
Jelili Ojodu, director of the program at APHL added, "Supporting state newborn screening programs in their effort to implement SCID testing means detecting this disorder in more babies and allowing them to get critical treatment. Our goals come back to one simple objective: saving more babies'' lives."
The Association of Public Health Laboratories (APHL) works to strengthen laboratory systems serving the public''s health in the US and globally. APHL''s member laboratories protect the public''s health by monitoring and detecting infectious and foodborne diseases, environmental contaminants, terrorist agents, genetic disorders in newborns and other diverse health threats.
Follow APHL on | | |
Image Available:
Contact:
Michelle Forman
240.485.2793
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.09.2014 - 14:05 Uhr
Sprache: Deutsch
News-ID 1305078
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SILVER SPRING, MD
Phone:
Kategorie:
Online Training
Anmerkungen:
Diese Pressemitteilung wurde bisher 175 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Newborn Screening Cooperative Agreement Awarded to APHL for Implementation of SCID Testing
"
steht unter der journalistisch-redaktionellen Verantwortung von
Association of Public Health Laboratories (APHL) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
